[EN] QUINUCLIDINE-3-ONE DERIVATIVES<br/>[FR] DÉRIVÉS DE QUINUCLIDINE-3-ONE
申请人:[en]APREA THERAPEUTICS AB
公开号:WO2022175402A1
公开(公告)日:2022-08-25
The invention relates to certain substituted quinuclidine-3-one compounds for use in the treatment of hyperproliferative disease, such as cancer, and diseases associated with inflammation. More particularly, the present invention relates to certain substituted 3-quinuclidinones, pharmaceutically acceptable salts thereof, pharmaceutical compositions containing the same, and to methods for using such compounds. In this manner, these compounds are of use for treating hyperproliferative diseases and inflammatory diseases.
Lowe III; Drozda; McLean, Journal of Medicinal Chemistry, 1994, vol. 37, # 18, p. 2831 - 2840